Minimal important difference in field walking tests in non-cystic fibrosis bronchiectasis following exercise training

Respiratory Medicine

Volumn 108, Issue 9, 2014, Pages 1303-1309

  Lee, A L ^a,b,c   Hill, C J ^b   Cecins, N ^d,e   Jenkins, S ^d,e,f   McDonald, C F ^b   Burge, A T ^a   Rautela, L ^b   Stirling, R G ^a,g   Thompson, P J ^d,e,f   Holland, A E ^a,b,h  

^a ALFRED HEALTH   (Australia)

^b AUSTIN HEALTH   (Australia)

^c THE UNIVERSITY OF MELBOURNE   (Australia)

^d SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^e Lung Institute of Western Australia   (Australia)

^f CURTIN UNIVERSITY   (Australia)

^g MONASH UNIVERSITY   (Australia)

^h LA TROBE UNIVERSITY   (Australia)

Author keywords

Bronchiectasis; Exercise capacity; Minimal important difference

Indexed keywords

6 MIN WALK DISTANCE; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BRONCHIECTASIS; CLINICAL ARTICLE; COMORBIDITY; EXERCISE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUNCTION TEST; HUMAN; INCREMENTAL SHUTTLE WALK DISTANCE; MALE; NON CYSTIC FIBROSIS BRONCHIECTASIS; PREDICTIVE VALUE; VERY ELDERLY; WALKING; WALKING SPEED; COMPLICATION; CYSTIC FIBROSIS; EXERCISE TEST; EXERCISE TOLERANCE; KINESIOTHERAPY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; TREATMENT OUTCOME; VITAL CAPACITY;

AGED; AGED, 80 AND OVER; BRONCHIECTASIS; CYSTIC FIBROSIS; EXERCISE TEST; EXERCISE THERAPY; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; HUMANS; MIDDLE AGED; TREATMENT OUTCOME; VITAL CAPACITY; WALKING;

EID: 84913620364     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2014.07.006     Document Type: Article

References (46)

1. P. King, S. Holdsworth, N. Freezer, E. Villanueva, and P. Holmes Characterisation of the onset and presenting clinical features of adult bronchiectasis Respir Med 100 2006 2183 2189
2. C. Wilson, P. Jones, C. O'Leary, P. Cole, and R. Wilson Validation of the St George's respiratory questionnaire in bronchiectasis Am J Respir Crit Care Med 156 1997 536 541
3. L. Hester, J. MacFarlane, H. Tedd, H. Jary, P. McAlinden, and L. Rostron Fatigue in bronchiectasis OMJ 105 2012 235 240
4. M. Pasteur, D. Bilton, and A. Hill British thoracic society guidelines for non-CF bronchiectasis Thorax 65 Suppl. 1 2010 i1 58
5. M. Murray, J. Govan, C. Doherty, A. Simpson, T. Wilkinson, and J. Chalmers A randomised controlled trial of nebulised gentamicin in non-cystic fibrosis bronchiectasis Am J Respir Crit Care Med 183 2011 491 499
6. M. Murray, J. Pentland, and A. Hill A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis Eur Respir J 34 2009 1086 1092
7. M. Liaw, Y. Wang, Y. Tsai, K. Huang, P. Chang, and Y. Chen Inspiratory muscle training in bronchiectasis patients: a prospective randomised controlled study Clin Rehabil 25 2011 524 536
8. P. Mandal, M. Sidhu, L. Kope, W. Pollock, L. Stevenson, and J. Pentland A pilot study of pulmonary rehabilitation and chest physiotherapy versus chest physiotherapy alone in bronchiectasis Respir Med 106 2012 1647 1654
9. C. Newall, R. Stockley, and S. Hill Exercise training and inspiratory muscle training in patients with bronchiectasis Thorax 60 2005 943 948
10. A. Lee, N. Cecins, C. Hill, A. Holland, L. Rautela, and R. Stirling The effects of pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis: protocol for a randomised controlled trial BMC Pulm Med 10 2010 5
11. H. Ong, A. Lee, C. Hill, A. Holland, and L. Denehy Effects of pulmonary rehabilitation in bronchiectasis: a retrospective study Chron Respir Dis 8 2011 21 30
12. R. Jaeschke, J. Singer, and G. Guyatt Measurement of health status: ascertaining the minimal clinically important difference Control Clin Trials 10 1989 407 415
13. G. Guyatt, D. Osoba, A. Wu, K. Wyrwich, and G. Norman Methods to explain the clinical significance of health status measures Mayo Clin Proc 77 2002 371 383
14. S. Haley, and M. Fragala-Pinkham Interpreting change scores of tests and measures used in physical therapy Phys Ther 86 2006 735 743
15. E. Juniper, G. Guyatt, A. Willan, and L. Griffith Determining a minimal important change in a disease-specific quality of life questionnaire J Clin Epidemiol 47 1994 81 87
16. R. Deyo, and R. Centor Assessing the responsiveness of functional scales to clinical change: an analogy to diagnostic test performance J Chron Dis 39 1986 897 906
17. J. Rejas, A. Pardo, and M. Ruiz Standard error of measurement as a valid alternative to minimally important difference for evaluating the magnitude of changes in patient-reported outcome measures J Clin Epidemiol 61 2008 350 356
18. A. Holland, C. Hill, M. Conron, P. Munro, and C. McDonald Small changes in six-minute walk distance are important in diffuse parenchymal lung disease Respir Med 103 2009 1430 1435
19. A. Holland, C. Hill, T. Rasekaba, A. Lee, M. Naughton, and C. McDonald Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease Arch Phys Med Rehabil 91 2010 221 225
20. M. Puhan, M. Mador, U. Held, R. Goldstein, G. Guyatt, and H. Schunemann Interpretation of treatment changes in 6-minute walk distance in patients with COPD Eur Respir J 32 2008 637 643
21. M. Smith, and A. Hill Evaluating success of therapy for bronchiectasis: what end points to use? Clin Chest Med 33 2012 329 349
22. American Thoracic Society ATS Statement: guidelines for the 6-minute walk test Am J Respir Crit Care Med 166 2002 111 117
23. S. Singh, M. Morgan, S. Scott, D. Walters, and A. Hardman Development of a shuttle walking test of disability in patients with chronic airway obstruction Thorax 47 1992 1019 1024
24. A. Lee, B. Button, S. Ellis, R. Stirling, J. Wilson, and A. Holland Clinical determinants of the 6-minute walk test in bronchiectasis Respir Med 103 2009 780 785
25. P. Jacques, M. Gazzana, D. Palombini, S. Barreto, P. de Tarso, and R. Dalcin Six-minute walk distance is not related to quality of life in patients with non-cystic fibrosis bronchiectasis J Bras Pneumol 38 2012 346 355
26. A.L. Lee, C.J. Hill, N. Cecins, S. Jenkins, C.F. McDonald, and A.T. Burge The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis - a randomised controlled trial Respir Res 15 2014 44 10.1186/1465-9921-15-44
27. D. Mahler, and C. Wells Evaluation of clinical methods for rating dyspnea Chest 93 1988 580 586
28. GOLD Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2013 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Available at: www.goldcopd.org [accessed 13.01.13]
29. M.A. Spruit, S.J. Singh, C. Garvey, R. ZuWallack, L. Nici, and C. Rochester An official American thoracic society/European respiratory society statement: key concepts and advances in pulmonary rehabilitation Am J Respir Crit Care Med 188 2013 e13 64
30. M. Martinez-Garcia, J. Soler-Cataluna, M. Perpina-Tordera, P. Roman-Sanchez, and S. Soriano Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis Chest 132 2007 1565 1572
31. R. Centor Signal detectability: the use of ROC curves and their analyses Med Decis Mak 11 1991 102 106
32. J. Cohen Statistical analysis for the behaviour sciences 2nd ed. 1988 Lawrence Erlbaum Associates, Inc New Jersey
33. D. Beaton, M. Boers, and G. Wells Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research Curr Opin Rheumatol 14 2002 109 114
34. S. Jenkins, N. Cecins, B. Camarri, C. Williams, P. Thompson, and P. Eastwood Regression equations to predict 6-minute walk distance in middle-aged and elderly adults Physiother Theory Pract 25 2009 516 522
35. V.S. Probst, N.A. Hernandes, D.C. Teixeira, J.M. Felcar, R.B. Mesquita, and C.G. Goncalves Reference values for the incremental shuttle walking test Respir Med 106 2012 243 248
36. M. Puhan, D. Chandra, Z. Mosenifar, A. Ries, B. Make, and N. Hansel The minimal important difference of exercise tests in severe COPD Eur Respir J 37 2011 784 790
37. M.I. Polkey, M.A. Spruit, L.D. Edwards, M.L. Watkins, V. Pinto-Plata, and J. Vestbo Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization Am J Respir Crit Care Med 187 2013 382 386
38. S.C. Mathai, M.A. Puhan, D. Lam, and R.A. Wise The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension Am J Respir Crit Care Med 186 2012 428 433
39. C. Gilbert, M.J. Brown, J.C. Cappelleri, M. Carlsson, and S.P. McKenna Estimating a minimally in important difference in pulmonary arterial hypertension following treatment with Sildenafil Chest 135 2009 137 142
40. R. du Bois, D. Weychker, C. Albera, W. Bradford, U. Costabel, and A. Kartashov Six-minute walk test in idiopathic pulmonary fibrosis Am J Respir Crit Care Med 183 2011 1231 1237
41. J. Swigris, F. Wamboldt, J. Behr, R. du Bois, T. King Jr., and G. Raghu The six-minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference Thorax 65 2010 173 177
42. S. Singh, P. Jones, R. Evans, and M. Morgan Minimal clinically important improvement for the incremental shuttle walk test Thorax 63 2008 775 777
43. C. Kwoh, G. O'Connor, and M. Regan-Smith Concordance between clinician and patient assessment of physical and mental health status J Rheumatol 19 1992 1031 1037
44. F. Wolfe, and T. Pincus Listening to the patient: a practical guide to self-report questionnaires in clinical care Arthritis Rheum 42 1999 1797 1808
45. A.A. De Camargo, T.S. Amaral, S.Z. Rached, R.A. Athanazio, F.C. Lanza, and L.M. Sampaio Incremental shuttle walking test: a reproducible and valid test to evaluate exercise tolerance in adults with noncystic fibrosis bronchiectasis Arch Phys Med Rehabil 95 2014 892 899
46. S. Jenkins, and N. Cecins Six-minute walk test in pulmonary rehabilitation: do all patients need a practice test? Respirol 15 2010 1192 1196